A novel de novo intronic variant in ITPR1 causes Gillespie syndrome
Authors:
- 5 May 2021
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (8) , 2315-2324
Abstract
Gillespie syndrome (GLSP) is characterized by bilateral symmetric partial aplasia of the iris presenting as a fixed and large pupil, cerebellar hypoplasia with ataxia, congenital hypotonia, and varying levels of intellectual disability. GLSP is caused by either biallelic or heterozygous, dominant‐negative, pathogenic variants in ITPR1. Here, we present a 5‐year‐old male with GLSP who was found to have a heterozygous, de novo intronic variant in ITPR1 (NM_001168272.1:c.5935‐17G > A) through genome sequencing (GS). Sanger sequencing of cDNA from this individual's fibroblasts showed the retention of 15 nucleotides from intron 45, which is predicted to cause an in‐frame insertion of five amino acids near the C‐terminal transmembrane domain of ITPR1. In addition, qPCR and cDNA sequencing demonstrated reduced expression of both ITPR1 alleles in fibroblasts when compared to parental samples. Given the close proximity of the predicted in‐frame amino acid insertion to the site of previously described heterozygous, de novo, dominant‐negative, pathogenic variants in GLSP, we predict that this variant also has a dominant‐negative effect on ITPR1 channel function. Overall, this is the first report of a de novo intronic variant causing GLSP, which emphasizes the utility of GS and cDNA studies for diagnosing patients with a clinical presentation of GLSP and negative clinical exome sequencing.Keywords
Funding Information
- Burroughs Wellcome Fund (Career Award for Medical Scientists)
- National Institutes of Health (T32 GM07526‐43, U01HG007709, U01HG007942, U01HG007709)
This publication has 27 references indexed in Scilit:
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxiaOrphanet Journal of Rare Diseases, 2012
- Linking structure to function: Recent lessons from inositol 1,4,5-trisphosphate receptor mutagenesisCell Calcium, 2010
- Human Splicing Finder: an online bioinformatics tool to predict splicing signalsNucleic Acids Research, 2009
- Total deletion and a missense mutation of ITPR1 in Japanese SCA15 familiesNeurology, 2008
- Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16Journal of Medical Genetics, 2007
- Deletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in HumansPLOS Genetics, 2007
- Inositol Trisphosphate Receptor Ca2+Release ChannelsPhysiological Reviews, 2007
- Aniridia, Cerebellar Ataxia, and Oligophrenia in SiblingsArchives of Ophthalmology (1950), 1965